Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Persistently high levels warrant medical investigation to identify any underlying cause
Section 11: Research Citations Here are some research citations that discuss potential effects of GLP-1 receptor agonists, including semaglutide, on metabolic and hormonal parameters, which may indirectly impact menstrual cycles: Baggio LL, Drucker DJ
Incretin therapies mimic or enhance the action of gut hormones primarily glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) to increase glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying and reduce appetite, leading to improved glycaemic control and weight loss
Rapid weight loss itself is also a pancreatitis risk factor
Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM
US$ 21.39
US$ 20.63
US$ 20.15
US$ 23.27
US$ 26.19
US$ 21.33
US$ 29.30
US$ 25.51
